Seeking men and women whose multiple myeloma has returned or has not responded to their most recent treatment for a study adding an investigational drug to the usual treatment.
Participants in this study will be randomly assigned to receive either an investigational drug combination or the usual treatment.
What we're hoping for
We are studying whether adding an investigational drug to the usual treatment for multiple myeloma that has recurred or has not responded to the most recent treatment is safe and effective in decreasing myeloma cancer cells.
ClinicalTrials.gov Identifier: NCT04975997